Darteil; Raphael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Darteil; Raphael.The latest application filed is for "use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders".

Company Profile

9.17.23

Darteil; Raphael - Villeurbanne FR
Darteil; Raphael - Lille FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for diagnosing and evaluating non-alcoholic steatohepatitis Grant 11,371,098 - Darteil , et al. June 28, 2	2022-06-28
Methods of treatment for cholestatic and fibrotic diseases Grant 11,103,484 - Darteil , et al. August 31, 2	2021-08-31
Methods of treatment for cholestatic and fibrotic diseases Grant 10,905,680 - Darteil , et al. February 2, 2	2021-02-02
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20200384105 - DARTEIL; Raphael ; et al.	2020-12-10
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20200316031 - DARTEIL; Raphael ; et al.	2020-10-08
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,722,575 - Darteil , et al.	2020-07-28
Non-invasive Diagnostic Of Non-alcoholic Steatohepatitis App 20190352715 - Darteil; Raphael ; et al.	2019-11-21
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20190275146 - Darteil; Raphael ; et al.	2019-09-12
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,350,181 - Darteil , et al. July 16, 2	2019-07-16
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20190083468 - DARTEIL; Raphael ; et al.	2019-03-21
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20190000813 - DARTEIL; Raphael ; et al.	2019-01-03
Methods of treatment for cholestatic and fibrotic diseases Grant 10,130,613 - Darteil , et al. November 20, 2	2018-11-20
Methods of treatment for cholestatic and fibrotic diseases Grant 10,130,612 - Darteil , et al. November 20, 2	2018-11-20
Methods of treatment for cholestatic and fibrotic diseases Grant 10,117,855 - Darteil , et al. November 6, 2	2018-11-06
Methods of treatment for cholestatic and fibrotic diseases Grant 10,117,856 - Darteil , et al. November 6, 2	2018-11-06
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20180280328 - DARTEIL; Raphael ; et al.	2018-10-04
Methods For Diagnosing And Evaluating Non-alcoholic Steatohepatitis App 20180265924 - Darteil; Raphael ; et al.	2018-09-20
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,022,343 - Darteil , et al. July 17, 2	2018-07-17
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092884 - Darteil; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092885 - Darteil; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180092886 - DARTEIL; Raphael ; et al.	2018-04-05
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20180085354 - Darteil; Raphael ; et al.	2018-03-29
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20170368007 - DARTEIL; Raphael ; et al.	2017-12-28
Methods Of Treatment For Cholestatic And Fibrotic Diseases App 20170290812 - DARTEIL; RAPHAEL ; et al.	2017-10-12
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,782,373 - Darteil , et al. October 10, 2	2017-10-10
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20170128399 - DARTEIL; Raphael ; et al.	2017-05-11
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,585,853 - Darteil , et al. March 7, 2	2017-03-07
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20160051501 - DARTEIL; Raphael ; et al.	2016-02-25
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,221,751 - Darteil , et al. December 29, 2	2015-12-29
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20150051145 - DARTEIL; Raphael ; et al.	2015-02-19
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 8,895,619 - Darteil , et al. November 25, 2	2014-11-25
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20140309165 - DARTEIL; Raphael ; et al.	2014-10-16
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 8,772,342 - Darteil , et al. July 8, 2	2014-07-08
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20120252725 - Darteil; Raphael ; et al.	2012-10-04
Acylated aminopropanediols and analogues and therapeutic uses thereof Grant 7,253,296 - Darteil , et al. August 7, 2	2007-08-07
Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof App 20060252827 - Darteil; Raphael ; et al.	2006-11-09
Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof App 20060154984 - Darteil; Raphael ; et al.	2006-07-13
Acylated aminopropanediols and analogues and therapeutic uses thereof App 20060069156 - Darteil; Raphael ; et al.	2006-03-30
Inducible expression systems employing PPAR transcriptional activators App 20040038249 - Darteil, Raphael ; et al.	2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.